Comprehensive Cancer Center

Director's Message

Types of Cancer

Departments

Breast Care Center

Centers of Excellence

Specialties

Gamma Knife Center

Integrated Brachytherapy

Cancer Patient Support

Clinical Trials

Research

Research Base

Accruals

Adverse Events DSMB

Annual Meeting

Links

Newsletter

Patient Registration

Protocols

Protocols

Quick Reference Guides

Results

Sites

Staff

Welcome

Additional Cancer Resources

Videos and Webcasts

Virtual Tours

Patient Information

Cancer Center Map

Friends of the Center

How You Can Help

WFUBMC Home

>

Comprehensive Cancer Center

>

Research Base

>

Protocols

>

83403

>

83403

83403 A Phase II Study of Single Agent Depsipeptide (FK228) in Recurrent, Platinum Sensitive Adeno-Carcinoma of the Ovary or Peritoneum Study officially closed to accrual for all sites effective 01/18/06 and terminated as of 03/28/07. Archived Amendments  l  Appendices  l  Annual Renewals: See below CCCWFU CCOP Research Base Home  l  Protocols  l  Welcome  l  Patient Registration  l  Accruals    Annual Meeting  l  Results  l  Adverse Events  l  Newsletter    Quick Reference Guides  l  Links  l  Sites  l  Staff  l  Contact Us               Archived Amendments  PDF Format Protocol Consent Forms (Stamped and MS Word)  List of Changes Appendices IRB Approval Letter           Termination       Termination Approval Am7 No new consent.  Please refer to Am6 version below. Am7 changes Appendices are located at the bottom of the screen. Am7 IRB approval Am6 07/27/05 Am6 stamped consent   Am6 consent MS Word Am6 changes Appendices are located at the bottom of the screen. Am6 IRB approval Am5 No new consent.  Please refer to Am2 version below. Am5 changes Appendices are located at the bottom of the screen. Am5 IRB approval Am4 No new consent.  Please refer to Am2 version below.   Am4 changes   Appendices are located at the bottom of the screen. Am4 IRB approval Am3 No new consent.  Please refer to Am2 version below.   Am3 changes Appendices are located at the bottom of the screen. Am3 IRB approval Am2 09/22/04 Am2 consent stamped   Am2 consent MS Word Am2 changes Appendices are located at the bottom of the screen. Am2 IRB approval   Am1 07/28/04 Am1 stamped consent   Am1 consent MSWord     Am1 changes Appendices for this protocol are located at the bottom of the screen. Am1 IRB approval Initial protocol 07/08/04 Initial stamped consent Initial consent MSWord     Appendices for this protocol are located at the bottom of the screen. Initial IRB approval Appendices Combined Appendices 06/29/05   Appendix A Data Submission Checklist 04/14/05   Appendix B Performance Status Criteria Appendix C New York Heart Assoc. Classifications  Appendix D Medications that May Cause QT Prolongation Appendix E Eligibility Checklist and Registration Form 06/29/05   Appendix F Depsipeptide Treatment Form 01/19/05   Appendix G Toxicity Reporting Form Appendix H Depsipeptide Tumor Evaluation Form Appendix I Depsipeptide Treatment Completion Form Appendix J Remarks Addenda Appendix K Off-Treatment Follow-Up Form Appendix L Cardiac Monitoring Guidelines   Appendix M VEG-F and Tissue Sample 09/27/04   Appendix N NIH Form 986   83403 WFU HIPAA Form    2005 Continuing Renewal   2005 Annual Renewal IRB Approval   2005 Annual Renewal Consent